Improving stem cell transplant for childhood leukemia
Treatments studied
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests different ways to manage stem cell transplants in children and young adults with acute lymphoblastic leukemia (ALL). It aims to find the best approach to improve outcomes and reduce complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 3 months and 25 years old.
- You must have a type of blood cancer called ALL and be scheduled for a stem cell transplant.
- Your leukemia must be in remission (no cancer cells seen in tests) before the transplant.
- You must have a suitable donor, which could be a matched sibling, an unrelated donor, or a family member with a partial match.
- You must agree to use birth control during the study if you are of childbearing age.
- You must be willing to follow the study procedures and give your consent (or have a parent/guardian do so).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special transplant approach for people with high-risk acute leukemia. It uses a stronger dose of radiation before transplant, followed by an infusion of immune cells (regulatory and conventional T cells) to help the transplant work better and fight the leukemia.
This trial tests whether children and teens with a specific type of acute lymphoblastic leukemia (ALL) do well after getting donor stem cells (an allogeneic transplant). It may help by using a standardized transplant approach for people in complete remission before the transplant.
This trial tests a stem cell transplant using a half-matched family donor for children with acute lymphoblastic leukemia (ALL) that is in remission. It compares two different types of radiation conditioning to prepare the body for the new cells, with the goal of improving outcomes.
This trial studies a new way to prepare adults with ALL for a stem cell transplant from a half-matched family donor. It compares two types of radiation-based conditioning to see which works better and has fewer side effects.
This trial tests two different conditioning regimens (total body irradiation or total marrow/lymphoid irradiation) before a stem cell transplant from a matched sibling donor for adults with acute lymphoblastic leukemia (ALL) that is in remission. The goal is to see which regimen works better and has fewer side effects.
This study tests two types of radiation-based conditioning (TBI or TMLI) before a stem cell transplant from a matched sibling donor, in children with ALL that is in remission. The goal is to see which approach works better and is safer.
Hear when a new Stem Cell Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.